{"component": "definition", "props": {"groups": [{"size": 6, "samples": [{"hash": "lV1V5mAgOkm", "uri": "/contracts/lV1V5mAgOkm#clarus", "label": "Underwriting Agreement (Aphria Inc.)", "score": 27.7939767283, "published": true}, {"hash": "aBnM7cz9NvT", "uri": "/contracts/aBnM7cz9NvT#clarus", "label": "Underwriting Agreement (Aphria Inc.)", "score": 27.7939767283, "published": true}, {"hash": "E2z7BeLPN5", "uri": "/contracts/E2z7BeLPN5#clarus", "label": "Underwriting Agreement (Aphria Inc.)", "score": 27.7939767283, "published": true}], "snippet_links": [{"key": "first-paragraph", "type": "definition", "offset": [40, 55]}, {"key": "this-agreement", "type": "clause", "offset": [59, 73]}], "snippet": "has the meaning ascribed thereto in the first paragraph of this Agreement;", "hash": "2d96f2e804f43be797f33e47b485cd96", "id": 1}, {"size": 4, "samples": [{"hash": "jiBjlxW4Y54", "uri": "/contracts/jiBjlxW4Y54#clarus", "label": "Subscription Receipt Indenture", "score": 26.6290212183, "published": true}, {"hash": "kX42qHh09cy", "uri": "/contracts/kX42qHh09cy#clarus", "label": "Underwriting Agreement (CRH Medical Corp)", "score": 24.6235455168, "published": true}, {"hash": "3dRYLdcQaWm", "uri": "/contracts/3dRYLdcQaWm#clarus", "label": "Agency Agreement (Swisher Hygiene Inc.)", "score": 22.1471594798, "published": true}], "snippet_links": [], "snippet": "means Clarus Securities Inc.;", "hash": "a862e1508685c4e1f585599187aeaf80", "id": 2}, {"size": 4, "samples": [{"hash": "7ig657bW0ii", "uri": "https://www.sec.gov/Archives/edgar/data/1031516/000106299317002805/exhibit99-3.htm", "label": "Notice (Merus Labs International Inc.)", "score": 16.4305270363, "published": false}, {"hash": "aUzARLhys05", "uri": "https://www.novamind.ca/docs/Novamind-Numinus-Information_Circular_for_Special_Meeting.pdf", "label": "Notice", "score": 15.1711156742, "published": false}, {"hash": "13ebVbHvA0X", "uri": "http://pdf.secdatabase.com/446/0001062993-17-002805.pdf", "label": "pdf.secdatabase.com", "score": 11.9404517454, "published": false}], "snippet_links": [], "snippet": "means Clarus Securities Inc.", "hash": "eb42e63f68b83fd33aa02d0650bf1308", "id": 3}, {"size": 3, "samples": [{"hash": "bCtBnHWh8eH", "uri": "/contracts/bCtBnHWh8eH#clarus", "label": "Purchase and Sale Agreement (Galera Therapeutics, Inc.)", "score": 30.7741273101, "published": true}, {"hash": "lsmYQLURqGp", "uri": "/contracts/lsmYQLURqGp#clarus", "label": "Purchase and Sale Agreement (Galera Therapeutics, Inc.)", "score": 30.3059548255, "published": true}, {"hash": "bM1XihSid9E", "uri": "/contracts/bM1XihSid9E#clarus", "label": "Purchase and Sale Agreement", "score": 26.1704312115, "published": true}], "snippet_links": [{"key": "a-delaware-limited-liability-company", "type": "clause", "offset": [28, 64]}, {"key": "the-investment-manager", "type": "clause", "offset": [66, 88]}, {"key": "for-purchaser", "type": "clause", "offset": [89, 102]}], "snippet": "means Clarus Ventures, LLC, a Delaware limited liability company, the investment manager for Purchaser.", "hash": "8880f2d1c9f9eb83fa2c82b269dfc490", "id": 4}, {"size": 2, "samples": [{"hash": "hF7aawRs7uu", "uri": "/contracts/hF7aawRs7uu#clarus", "label": "Investors\u2019 Rights Agreement (Praxis Precision Medicines, Inc.)", "score": 32.8384668036, "published": true}, {"hash": "11jpKucyRCh", "uri": "/contracts/11jpKucyRCh#clarus", "label": "Investors\u2019 Rights Agreement (Praxis Precision Medicines, Inc.)", "score": 31.7323750856, "published": true}], "snippet_links": [{"key": "interest-in-the-company", "type": "definition", "offset": [99, 122]}], "snippet": "means Clarus Lifesciences III, L.P. or any transferee, assignee or successor in such stockholder\u2019s interest in the Company.", "hash": "ba8bfa70d8471e70ee5a89ef155d8b8f", "id": 5}, {"size": 2, "samples": [{"hash": "2DxQ45iR8tp", "uri": "/contracts/2DxQ45iR8tp#clarus", "label": "Investors\u2019 Rights Agreement", "score": 31.340862423, "published": true}, {"hash": "6sz079XcUVF", "uri": "/contracts/6sz079XcUVF#clarus", "label": "Investors\u2019 Rights Agreement (AVROBIO, Inc.)", "score": 29.3942505133, "published": true}], "snippet_links": [], "snippet": "means Clarus Lifesciences III, LLP.", "hash": "b7c17687cb93b541b033070fedb01a6d", "id": 6}, {"size": 2, "samples": [{"hash": "kXJ9Pj63e1J", "uri": "/contracts/kXJ9Pj63e1J#clarus", "label": "Loan Agreement (Clarus Corp)", "score": 19.4216290212, "published": true}, {"hash": "dlF7nXEitxO", "uri": "https://www.claruscorp.com/all-sec-filings/content/0001144204-10-031984/0001144204-10-031984.pdf", "label": "www.claruscorp.com", "score": 6.7837097878, "published": false}], "snippet_links": [{"key": "a-corporation", "type": "clause", "offset": [26, 39]}, {"key": "organized-and-existing", "type": "clause", "offset": [40, 62]}, {"key": "the-laws", "type": "definition", "offset": [69, 77]}, {"key": "state-of-delaware", "type": "clause", "offset": [85, 102]}], "snippet": "means Clarus Corporation, a corporation organized and existing under the laws of the State of Delaware.", "hash": "668b624a53dd8ab7b94cd7ee7ea30ec2", "id": 7}, {"size": 1, "samples": [{"hash": "5BibBzkiX0t", "uri": "/contracts/5BibBzkiX0t#clarus", "label": "Arrangement Agreement (United Industries Corp)", "score": 21.0, "published": true}], "snippet_links": [{"key": "financial-advisor", "type": "clause", "offset": [45, 62]}, {"key": "board-of-directors", "type": "clause", "offset": [77, 95]}], "snippet": "means Clarus Securities Inc., in its role as financial advisor to the Nu-Gro Board of Directors;", "hash": "f677b5949ec0aa8b521ff13ee36bb2ca", "id": 8}, {"size": 1, "samples": [{"hash": "jpo3vZLGEEI", "uri": "https://ir.praxismedicines.com/static-files/94db8090-2f76-4ee5-b8c7-127cc637207e", "label": "ir.praxismedicines.com", "score": 16.6388951213, "published": false}], "snippet_links": [{"key": "interest-in-the-company", "type": "definition", "offset": [99, 122]}, {"key": "common-stock", "type": "definition", "offset": [125, 137]}, {"key": "shares-of-the-company", "type": "definition", "offset": [145, 166]}, {"key": "par-value", "type": "definition", "offset": [183, 192]}], "snippet": "means Clarus Lifesciences III, L.P. or any transferee, assignee or successor in such stockholder\u2019s interest in the Company. \u201cCommon Stock\u201d means shares of the Company\u2019s common stock, par value $0.0001 per share.", "hash": "52a8776574a7d80cf38d0f3ef871046a", "id": 9}, {"size": 1, "samples": [{"hash": "7gZOpqf21af", "uri": "/contracts/7gZOpqf21af#clarus", "label": "Subscription Receipt Agreement (Swisher Hygiene Inc.)", "score": 22.1471594798, "published": true}], "snippet_links": [{"key": "the-preamble", "type": "clause", "offset": [38, 50]}, {"key": "to-this-agreement", "type": "clause", "offset": [51, 68]}], "snippet": "has the meaning attributed thereto in the preamble to this Agreement;", "hash": "23737282f8fb32fae14fda543d752803", "id": 10}], "next_curs": "ClMSTWoVc35sYXdpbnNpZGVyY29udHJhY3Rzci8LEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIPY2xhcnVzIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"size": 33, "title": "Clarus", "snippet": "has the meaning ascribed thereto in the first paragraph of this Agreement;", "id": "clarus", "examples": ["<strong>Clarus</strong> will take all reasonable steps to prevent security breaches in provision of the Services but does not guarantee security.", "By its General Partner, <strong>Clarus</strong> Ventures II GP, LP By its General Partner, <strong>Clarus</strong> Ventures II, LLC /s/ \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587 By: \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587\u2587 Managing Director [SIGNATURE PAGE TO RESTORATION ROBOTICS, INC.", "<strong>Clarus</strong> makes no representation and gives no warranty that any Outages or Service Interruptions will be resolved in accordance with the Service Level Agreement.", "Except with respect to Section 13, Section 17 and Section 18, all transactions and notices on behalf of the Underwriters hereunder or contemplated hereby may be carried out or given on behalf of the Underwriters by <strong>Clarus</strong> and the Underwriters shall in good faith discuss with each other the nature of any such transactions and notices prior to giving effect thereto or the delivery thereof, as the case may be.", "Where <strong>Clarus</strong> agrees in writing to accept payment in any other currency, the Service Fee may be subject to change in accordance with exchange rate fluctuations and any additional costs associated with conversion of payment made to Pounds Sterling shall be met by the Customer.", "The percentage of the Offered Shares to be severally purchased and paid for by each of the Underwriters shall be as follows: <strong>Clarus</strong> Securities Inc.", "Payment shall be considered made on the date the funds are received by <strong>Clarus</strong>.", "<strong>Clarus</strong> will undertake a service availability check before assigning any services plans to the Customer.", "The Customer shall meet all reasonable costs, including legal fees, incurred by <strong>Clarus</strong> in recovering any sums due under this Agreement.", "All notices to Holder shall be addressed as follows until the Company receives notice of a change of address in connection with a transfer or otherwise: SVB Financial Group Attn: Treasury Department \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587, \u2587\u2587 \u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587, \u2587\u2587 \u2587\u2587\u2587\u2587\u2587 Telephone: \u2587\u2587\u2587-\u2587\u2587\u2587-\u2587\u2587\u2587\u2587 Facsimile: \u2587\u2587\u2587-\u2587\u2587\u2587-\u2587\u2587\u2587\u2587 Notice to the Company shall be addressed as follows until Holder receives notice of a change in address: <strong>Clarus</strong> Therapeutics, Inc."], "related": [["summit", "Summit", "Summit"], ["insight", "Insight", "Insight"], ["beacon", "Beacon", "Beacon"], ["microenterprise", "Microenterprise", "Microenterprise"], ["arena", "Arena", "Arena"]], "related_snippets": [], "updated": "2025-07-07T00:35:48+00:00"}, "json": true, "cursor": ""}}